NNOX
Nano-X Imaging Ltd.
NNOX Q2 2026 earnings
Published Sep 9, 2026
AI summary
- Revenue $4.16M, up 37% from $3.04M a year ago.
- GAAP EPS −$0.79, down from −$0.23 a year ago.
- Second quarter revenue rose 37% year-over-year to $4.2 million, driven by the Nanox Health IT business.
- The company recorded a $40.7 million impairment charge on intangible assets related to its AI solutions unit.
- GAAP net loss widened to $55.5 million, compared to a $14.7 million loss in the same quarter last year.
Results vs analyst consensus
Revenue
Reported
$4.16M
Consensus not captured before release
Not verified against provider data.
+37% YoY
EPS · GAAP
Reported · GAAP diluted EPS
−$0.79
Consensus basis not comparable
Prior year: −$0.23
Consensus: Yahoo Finance · Q2 2026
Revenue display rounded; difference uses exact result.
Next quarter outlook
No guidance in this release.
What to watch
- The company recorded a $40.7 million impairment charge on intangible assets due to a decline in share price.
- A class action complaint was filed against the company in June 2026 regarding past business disclosures.
- The company is undergoing a restructuring of its Korea operations, including a 67% reduction in workforce.
Read original report
Source: Nano-X Imaging Ltd. press release · SEC Form 6-K exhibit 99.1